Latest News & Updates

Breaking News

  • 14 minutes ago

  • Simantini Singh Deo

Novo Nordisk And Aspect Biosystems Advance To Next Phase Of Their Collaboration To Create Curative Diabetes Treatments
Breaking News
BrightInsight Secures Multi-Million Dollar Investment To Accelerate Its AI-Powered Medication Persistence & Adherence Solutions

Simantini Singh Deo

Other trending news you may like to read

Novo Nordisk And Aspect Biosystems Advance To Next Phase Of Their Collaboration To Create Curative Diabetes Treatments

Novo Nordisk and Aspect deepen their alliance to accelerate scalable, potentially curative cell therapies for diabetes.

Simantini Singh Deo

Pharma Now

BrightInsight Secures Multi-Million Dollar Investment To Accelerate Its AI-Powered Medication Persistence & Adherence Solutions

BrightInsight raises $13M to expand its AI-enabled platform addressing medication non-adherence across chronic diseases globally.

Simantini Singh Deo

Pharma Now

Capricor Therapeutics Prepares Full HOPE-3 Study Report For FDA After Phase 3 Results Show Promise In Duchenne Muscular Dystrophy

Capricor moves forward with FDA review of Deramiocel, submitting full HOPE-3 data to address CRL with no new trials required.

Simantini Singh Deo

Pharma Now

BrightInsight Expands Executive Leadership Team With Three Senior Appointments As Global Growth Accelerates

BrightInsight appoints new COO, SVP, and VP of Product to scale operations and accelerate digital health innovation for biopharma.

Simantini Singh Deo

Pharma Now